Cancer and Non-cancer Effects following Ionizing Irradiation
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 49731
Special Issue Editor
Interests: radiation protection; deterministic effects (tissue reactions); circulatory disease; ocular disease
Special Issue Information
Dear Colleagues,
Cancers (IF 5.575) will have the special issue "Cancer and Non-cancer Effects following Ionizing Irradiation". This special issue aims to serve as a forum to gather the latest developments and discuss future developments in the field of normal tissue responses to ionizing radiation exposure. “Cancer” here means cancer following occupational or environmental radiation exposure or secondary cancer following radiotherapy. “Non-cancer effects” here means tissue reactions (deterministic effects) and other non-cancer diseases (e.g. ophthalmological, circulatory or neurological) following occupational or environmental radiation exposure, or normal tissue complications following radiotherapy. Studies on mitigation strategies, bioindicators, biomarkers, mechanistic modeling, adverse outcome pathway (AOP) approach are also relevant.
We would welcome the submission of any type of quality manuscripts, e.g., original manuscripts reporting biological findings (at the cellular, tissue or organismal levels) or epidemiological findings (in patients, medical or other occupational workers and the public), and review manuscripts on current knowledge and future perspectives, but with explicit relevance to cancer (e.g., from the aspects of carcinogenesis, cancer radiotherapy and diagnosis).
Dr. Nobuyuki Hamada
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.